-
-
-
-
-
-
-
Goldman Sachs Resumes Neurocrine Bio. (NBIX) at Buy
-
-
-
-
-
-
-
Neurocrine Bio. (NBIX) PT Raised to $215 at H.C. Wainwright
-
-
-
-
-
-
-
Neurocrine Biosciences (NBIX) Appoints Lewis Choi as Chief Information Officer
-
-
-
-
-
-
-
Neurocrine Biosciences Reports First Quarter 2024 Financial Results
-
-
-
-
-
-
-
Neurocrine Biosciences (NBIX), Intra-Cellular Therapies (ITCI), and Biohaven Pharmaceutical (BHVN) Are Top Potential Acquisition Targets for Biogen (BIIB) - Mizuho Investor Survey
-
-
-
-
-
-
-
Neurocrine Biosciences Announces Appointment of Shalini Sharp to Board of Directors
-
-
-
-
-
-
-
After-Hours Movers 05/23: (TSC) (TLYS) (SPHS) Higher; (ANW) (NBIX) (OOMA) Lower (more...)
-
1,178,806 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

